Rheumatology Doctors in Salem, VA Accepting Medicare

5 Rheumatology doctors found. Showing 1 - 5

Dr. Garry Bayliss, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1930 Braeburn Cir, Salem, VA 24153 Phone: 540-772-3707    Fax: 540-772-3739

Dr. Joseph Lemmer, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1930 Braeburn Cir, Salem, VA 24153 Phone: 540-772-3707    Fax: 540-772-3739

Catherine L. Daniel, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463

Dr. Sorina Dancea, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1930 Braeburn Cir, Salem, VA 24153 Phone: 540-444-5600    Fax: 540-444-5617

Dr. William Blaylock, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1930 Braeburn Cir, Salem, VA 24153 Phone: 540-444-5600    Fax: 540-444-5617

News Archive

Mild autumn could bring more misery for hayfever sufferers

Researchers at the University of Leicester have recorded a rare type of pollen that is a potent trigger of hayfever and asthma symptoms at record levels for the first time in four decades.

Health industry raising alarms about cuts to Medicare after super committee failure

Automatic Medicare cuts triggered by the congressional super committee's failure would hit hospitals harder than any other health industry, according to an analysis from Avalere Health. The report puts hard numbers to across-the-board cuts that stakeholders have mostly viewed in broad, general terms. But Avalere chief executive Dan Mendelson cautioned that the figures also assume the automatic cuts will actually happen -; an assumption he's not ready to make.

New version of InSyBio Suite launched to revolutionize biomarker discovery

The new version of InSyBio Suite has a significant increase in speed and refinement of the predictive biomarkers process.

Acceleron, Celgene to give oral presentations on beta-thalassemia, myelodysplastic syndromes at EHA meeting

Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy from June 12-15, 2014.

Read more Medical News

› Verified 5 days ago